Shanie Everts

Title: Shanie Everts: Innovator in Crystalline Compounds

Introduction

Shanie Everts is a notable inventor based in Maasbracht, Netherlands. She has made significant contributions to the field of pharmaceuticals, particularly in the development of crystalline compounds. Her innovative work has led to the creation of a patent that addresses important medical applications.

Latest Patents

Shanie Everts holds a patent for a crystalline spirocyclic compound, which includes a dosage form and methods for using it in the treatment of diseases. The patent describes a crystalline compound of (S)-ethyl 8-(2-amino-6-((R)-1-(5-chloro-[1,1'-biphenyl]-2-yl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)-2,8-diazaspiro[4.5]decane-3-carboxylate. This compound exhibits an XRPD pattern with a characteristic peak at 19.05±0.20 (° 2θ). Additionally, the patent includes a pharmaceutical composition containing the compound, a dosage form with one or more pharmaceutically acceptable excipients, and methods for crystallizing or recrystallizing the compound. Furthermore, it outlines a method for treating or preventing diseases using this innovative compound.

Career Highlights

Shanie Everts is currently employed at Altavant Sciences GmbH, where she continues to advance her research and development efforts. Her work focuses on creating effective pharmaceutical solutions that can improve patient outcomes.

Collaborations

Shanie collaborates with her coworker, Daniel Patterson, to further enhance the research and development processes at Altavant Sciences GmbH. Their teamwork is essential in driving innovation within the company.

Conclusion

Shanie Everts is a pioneering inventor whose work in crystalline compounds has the potential to make a significant impact in the pharmaceutical industry. Her dedication to innovation and collaboration exemplifies the spirit of advancement in medical science.